Willingness to Receive COVID-19 Vaccination among Older Adults in Saudi Arabia: A Community-Based Survey
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Sample
2.2. Variables
2.3. Statistical Analyses
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- FDA. US Food & Drug Administration: COVID-19 Vaccines. Available online: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines (accessed on 9 August 2021).
- MacDonald, N.E. Vaccine hesitancy: Definition, scope and determinants. Vaccine 2015, 33, 4161–4164. [Google Scholar] [CrossRef] [PubMed]
- WHO. Ten Health Issues WHO Will Tackle This Year. Available online: https://www.who.int/vietnam/news/feature-stories/detail/ten-threats-to-global-health-in-2019 (accessed on 1 August 2021).
- Johnson, N.F.; Velásquez, N.; Restrepo, N.J.; Leahy, R.; Gabriel, N.; El Oud, S.; Zheng, M.; Manrique, P.; Wuchty, S.; Lupu, Y. The online competition between pro-and anti-vaccination views. Nature 2020, 582, 230–233. [Google Scholar] [CrossRef] [PubMed]
- Roozenbeek, J.; Schneider, C.R.; Dryhurst, S.; Kerr, J.; Freeman, A.L.; Recchia, G.; Van Der Bles, A.M.; Van Der Linden, S. Susceptibility to misinformation about COVID-19 around the world. R. Soc. Open Sci. 2020, 7, 201199. [Google Scholar] [CrossRef] [PubMed]
- MOH. COVID-19 Vaccines. Available online: https://covid19awareness.sa/en/archives/10691 (accessed on 2 August 2021).
- Bloom, B.R.; Nowak, G.J.; Orenstein, W. “When will we have a vaccine?”—Understanding questions and answers about Covid-19 vaccination. N. Engl. J. Med. 2020, 383, 2202–2204. [Google Scholar] [CrossRef]
- Betsch, C.; Böhm, R.; Korn, L. Inviting free-riders or appealing to prosocial behavior? game-theoretical reflections on communicating herd immunity in vaccine advocacy. Health Psychol. 2013, 32, 978. [Google Scholar] [CrossRef] [Green Version]
- Alfageeh, E.I.; Alshareef, N.; Angawi, K.; Alhazmi, F.; Chirwa, G.C. Acceptability of a COVID-19 vaccine among the Saudi population. Vaccines 2021, 9, 226. [Google Scholar] [CrossRef]
- Paul, E.; Steptoe, A.; Fancourt, D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg. Health-Eur. 2021, 1, 100012. [Google Scholar] [CrossRef]
- Betsch, C.; Böhm, R.; Chapman, G.B. Using behavioral insights to increase vaccination policy effectiveness. Policy Insights Behav. Brain Sci. 2015, 2, 61–73. [Google Scholar] [CrossRef]
- Kang, S.-J.; Jung, S.I. Age-related morbidity and mortality among patients with COVID-19. Infect. Chemother. 2020, 52, 154. [Google Scholar] [CrossRef]
- McElhaney, J.E.; Verschoor, C.; Pawelec, G. Zoster Vaccination in Older Adults: Efficacy and Public Health Implications. J. Gerontol. Ser. A 2019, 74, 1239–1243. [Google Scholar] [CrossRef]
- Krueger, P.; St Amant, O.; Loeb, M. Predictors of Pneumococcal Vaccination among Older Adults with Pneumonia: Findings from the Community Acquired Pneumonia Impact Study. BMC Geriatr. 2010, 10, 1–9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Leung, C. Risk factors for predicting mortality in elderly patients with COVID-19: A review of clinical data in China. Mech. Ageing Dev. 2020, 188, 111255. [Google Scholar] [CrossRef] [PubMed]
- Zhou, F.; Yu, T.; Du, R.; Fan, G.; Liu, Y.; Liu, Z.; Xiang, J.; Wang, Y.; Song, B.; Gu, X. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020, 395, 1054–1062. [Google Scholar] [CrossRef]
- Hu, X.; Xing, Y.; Jia, J.; Ni, W.; Liang, J.; Zhao, D.; Song, X.; Gao, R.; Jiang, F. Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19. Sci. Total Environ. 2020, 728, 138812. [Google Scholar] [CrossRef]
- Leung, C. Clinical features of deaths in the novel coronavirus epidemic in China. Rev. Med. Virol. 2020, 30, e2103. [Google Scholar] [CrossRef]
- Cox, L.S.; Bellantuono, I.; Lord, J.M.; Sapey, E.; Mannick, J.B.; Partridge, L.; Gordon, A.L.; Steves, C.J.; Witham, M.D. Tackling immunosenescence to improve COVID-19 outcomes and vaccine response in older adults. Lancet Healthy Longev. 2020, 1, e55–e57. [Google Scholar] [CrossRef]
- Betsch, C.; Rossmann, C.; Pletz, M.W.; Vollmar, H.C.; Freytag, A.; Wichmann, O.; Hanke, R.; Hanke, W.; Heinemeier, D.; Schmid, P. Increasing influenza and pneumococcal vaccine uptake in the elderly: Study protocol for the multi-methods prospective intervention study Vaccination 60+. BMC Public Health 2018, 18, 1–13. [Google Scholar] [CrossRef]
- Qattan, A.; Alshareef, N.; Alsharqi, O.; Al Rahahleh, N.; Chirwa, G.C.; Al-Hanawi, M.K. Acceptability of a COVID-19 vaccine among healthcare workers in the Kingdom of Saudi Arabia. Front. Med. 2021, 8, 83. [Google Scholar] [CrossRef]
- Wang, J.; Jing, R.; Lai, X.; Zhang, H.; Lyu, Y.; Knoll, M.D.; Fang, H. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines 2020, 8, 482. [Google Scholar] [CrossRef]
- Quinn, S.C.; Jamison, A.M.; An, J.; Hancock, G.R.; Freimuth, V.S. Measuring vaccine hesitancy, confidence, trust and flu vaccine uptake: Results of a national survey of White and African American adults. Vaccine 2019, 37, 1168–1173. [Google Scholar] [CrossRef] [PubMed]
- Sherman, S.M.; Smith, L.E.; Sim, J.; Amlôt, R.; Cutts, M.; Dasch, H.; Rubin, G.J.; Sevdalis, N. COVID-19 vaccination intention in the UK: Results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum. Vaccines Immunother. 2021, 17, 1612–1621. [Google Scholar] [CrossRef]
- Al-Hanawi, M.K.; Angawi, K.; Alshareef, N.; Qattan, A.; Helmy, H.Z.; Abudawood, Y.; Alqurashi, M.; Kattan, W.M.; Kadasah, N.A.; Chirwa, G.C. Knowledge, attitude and practice toward COVID-19 among the public in the Kingdom of Saudi Arabia: A cross-sectional study. Front. Public Health 2020, 8, 217. [Google Scholar] [CrossRef] [PubMed]
- Harapan, H.; Wagner, A.L.; Yufika, A.; Winardi, W.; Anwar, S.; Gan, A.K.; Setiawan, A.M.; Rajamoorthy, Y.; Sofyan, H.; Mudatsir, M. Acceptance of a COVID-19 vaccine in Southeast Asia: A cross-sectional study in Indonesia. Front. Public Health 2020, 8, 381. [Google Scholar] [CrossRef]
- Al-Qerem, W.A.; Jarab, A.S. COVID-19 vaccination acceptance and its associated factors among a Middle Eastern population. Front. Public Health 2021, 9, 34. [Google Scholar] [CrossRef]
- Al-Hanawi, M.K.; Ahmad, K.; Haque, R.; Keramat, S.A. Willingness to receive COVID-19 vaccination among adults with chronic diseases in the Kingdom of Saudi Arabia. J. Infect. Public Health 2021, 14, 1489–1496. [Google Scholar] [CrossRef]
- Al-Mohaithef, M.; Padhi, B.K. Determinants of COVID-19 vaccine acceptance in Saudi Arabia: A web-based national survey. J. Multidiscip. Healthc. 2020, 13, 1657. [Google Scholar] [CrossRef]
- Daly, M.; Jones, A.; Robinson, E. Public Trust and Willingness to Vaccinate against COVID-19 in the US from October 14, 2020, to March 29, 2021. JAMA 2021, 325, 2397–2399. [Google Scholar] [CrossRef]
- Loomba, S.; de Figueiredo, A.; Piatek, S.J.; de Graaf, K.; Larson, H.J. Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nat. Hum. Behav. 2021, 5, 337–348. [Google Scholar] [CrossRef] [PubMed]
- Nikolovski, J.; Koldijk, M.; Weverling, G.J.; Spertus, J.; Turakhia, M.; Saxon, L.; Gibson, M.; Whang, J.; Sarich, T.; Zambon, R. Factors indicating intention to vaccinate with a COVID-19 vaccine among older US Adults. PLoS ONE 2021, 16, e0251963. [Google Scholar] [CrossRef] [PubMed]
- Sallam, M.; Dababseh, D.; Eid, H.; Al-Mahzoum, K.; Al-Haidar, A.; Taim, D.; Yaseen, A.; Ababneh, N.A.; Bakri, F.G.; Mahafzah, A. High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: A study in Jordan and Kuwait among other Arab countries. Vaccines 2021, 9, 42. [Google Scholar] [CrossRef]
- Poland, G.A.; Ovsyannikova, I.G.; Jacobson, R.M. Adversomics: The emerging field of vaccine adverse event immunogenetics. Pediatric Infect. Dis. J. 2009, 28, 431. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Galbadage, T.; Peterson, B.M.; Awada, J.; Buck, A.S.; Ramirez, D.A.; Wilson, J.; Gunasekera, R.S. Systematic review and meta-analysis of sex-specific COVID-19 clinical outcomes. Front. Med. 2020, 7, 348. [Google Scholar] [CrossRef]
- Klein, S.L.; Jedlicka, A.; Pekosz, A. The Xs and Y of immune responses to viral vaccines. Lancet Infect. Dis. 2010, 10, 338–349. [Google Scholar] [CrossRef]
- Fisher, K.A.; Bloomstone, S.J.; Walder, J.; Crawford, S.; Fouayzi, H.; Mazor, K.M. Attitudes toward a potential SARS-CoV-2 vaccine: A survey of US adults. Ann. Intern. Med. 2020, 173, 964–973. [Google Scholar] [CrossRef]
- Clouston, S.A.; Manganello, J.A.; Richards, M. A life course approach to health literacy: The role of gender, educational attainment and lifetime cognitive capability. Age Ageing 2017, 46, 493–499. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Almaghaslah, D.; Alsayari, A.; Kandasamy, G.; Vasudevan, R. COVID-19 Vaccine Hesitancy among Young Adults in Saudi Arabia: A Cross-Sectional Web-Based Study. Vaccines 2021, 9, 330. [Google Scholar] [CrossRef]
- Reno, C.; Maietti, E.; Fantini, M.P.; Savoia, E.; Manzoli, L.; Montalti, M.; Gori, D. Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy. Vaccines 2021, 9, 378. [Google Scholar] [CrossRef]
- Malani, P.N.; Solway, E.; Kullgren, J.T. Older Adults’ Perspectives on a COVID-19 Vaccine. In JAMA Health Forum; American Medical Association: Chicago, IL, USA, 2020; p. e201539. [Google Scholar]
- Solís Arce, J.S.; Warren, S.S.; Meriggi, N.F.; Scacco, A.; McMurry, N.; Voors, M.; Syunyaev, G.; Malik, A.A.; Aboutajdine, S.; Adeojo, O. COVID-19 vaccine acceptance and hesitancy in low-and middle-income countries. Nat. Med. 2021. [Google Scholar] [CrossRef]
- Callaway, E. Russia’s fast-track coronavirus vaccine draws outrage over safety. Nature 2020, 584, 334–335. [Google Scholar] [CrossRef]
- Goldstein, S.; MacDonald, N.E.; Guirguis, S. Health communication and vaccine hesitancy. Vaccine 2015, 33, 4212–4214. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Puri, N.; Coomes, E.A.; Haghbayan, H.; Gunaratne, K. Social media and vaccine hesitancy: New updates for the era of COVID-19 and globalized infectious diseases. Hum. Vaccines Immunother. 2020, 16, 2586–2593. [Google Scholar] [CrossRef] [PubMed]
- Savulescu, J. Good reasons to vaccinate: Mandatory or payment for risk? J. Med. Ethics 2021, 47, 78–85. [Google Scholar] [CrossRef]
- Caserotti, M.; Girardi, P.; Rubaltelli, E.; Tasso, A.; Lotto, L.; Gavaruzzi, T. Associations of COVID-19 risk perception with vaccine hesitancy over time for Italian residents. Soc. Sci. Med. 2021, 272, 113688. [Google Scholar] [CrossRef] [PubMed]
- Ruiz, J.B.; Bell, R.A. Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey. Vaccine 2021, 39, 1080–1086. [Google Scholar] [CrossRef] [PubMed]
- Liao, Q.; Cowling, B.J.; Lam, W.W.T.; Fielding, R. Factors affecting intention to receive and self-reported receipt of 2009 pandemic (H1N1) vaccine in Hong Kong: A longitudinal study. PLoS ONE 2011, 6, e17713. [Google Scholar] [CrossRef] [Green Version]
- Chor, J.S.; Ngai, K.L.; Goggins, W.B.; Wong, M.C.; Wong, S.Y.; Lee, N.; Leung, T.-f.; Rainer, T.H.; Griffiths, S.; Chan, P.K. Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: Two questionnaire surveys. BMJ 2009, 339, b3391. [Google Scholar] [CrossRef] [Green Version]
- Lin, C.J.; Nowalk, M.P.; Toback, S.L.; Rousculp, M.D.; Raymund, M.; Ambrose, C.S.; Zimmerman, R.K. Importance of vaccination habit and vaccine choice on influenza vaccination among healthy working adults. Vaccine 2010, 28, 7706–7712. [Google Scholar] [CrossRef]
- Wang, K.; Wong, E.L.Y.; Ho, K.F.; Cheung, A.W.L.; Chan, E.Y.Y.; Yeoh, E.K.; Wong, S.Y.S. Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: A cross-sectional survey. Vaccine 2020, 38, 7049–7056. [Google Scholar] [CrossRef]
Variable | No Intention to Receive COVID-19 Vaccine (n = 274) | Intention to Receive COVID-19 Vaccine (n = 214) | Total (n = 488) | p-Value | |||
---|---|---|---|---|---|---|---|
n | % | n | % | n | % | ||
Age (years) | |||||||
50 to 59 | 156 | 56.93 | 120 | 56.07 | 276 | 56.56 | 0.849 |
≥60 | 118 | 43.07 | 94 | 43.93 | 212 | 43.44 | |
Gender | |||||||
Female | 119 | 43.43 | 66 | 30.48 | 185 | 37.91 | <0.001 *** |
Male | 155 | 56.57 | 148 | 69.16 | 303 | 62.09 | |
Marital Status | |||||||
Unmarried | 31 | 11.31 | 20 | 9.35 | 51 | 10.45 | 0.481 |
Married | 243 | 88.69 | 194 | 90.65 | 437 | 89.55 | |
Educational attainment | |||||||
High school or below | 71 | 25.91 | 51 | 23.83 | 122 | 25.00 | 0.646 |
University degree | 119 | 43.43 | 89 | 41.59 | 208 | 42.62 | |
Postgraduate degree | 84 | 30.66 | 74 | 34.58 | 158 | 32.38 | |
Employment status | |||||||
Government employee | 65 | 23.72 | 63 | 29.44 | 128 | 26.23 | 0.270 |
Private sector employee | 39 | 14.23 | 20 | 9.35 | 59 | 12.09 | |
Unemployed | 36 | 13.14 | 29 | 13.55 | 65 | 13.32 | |
Retired | 134 | 48.91 | 102 | 47.66 | 236 | 48.36 | |
Monthly Income (in SR) | |||||||
˂3000 | 16 | 5.84 | 12 | 5.61 | 28 | 5.74 | 0.582 |
3000–4999 | 9 | 3.28 | 14 | 6.54 | 23 | 4.71 | |
5000–6999 | 16 | 5.84 | 10 | 4.6 | 26 | 5.33 | |
7000–9999 | 26 | 9.49 | 19 | 8.88 | 45 | 9.22 | |
10,000–14,999 | 56 | 20.44 | 37 | 17.29 | 93 | 19.06 | |
15,000–19,999 | 60 | 21.90 | 44 | 20.56 | 104 | 21.31 | |
20,000–29,999 | 47 | 17.15 | 33 | 15.42 | 80 | 16.39 | |
≥30,000 | 44 | 16.06 | 45 | 21.03 | 89 | 18.24 | |
Health status | |||||||
No chronic disease | 145 | 52.92 | 86 | 40.19 | 231 | 47.34 | <0.001 *** |
Chronic disease diagnosis | 129 | 47.08 | 128 | 59.81 | 257 | 52.66 | |
Vaccination history | |||||||
Never received flu vaccine | 158 | 57.66 | 75 | 35.05 | 233 | 47.75 | <0.001 *** |
Have received flu vaccine | 116 | 42.34 | 139 | 64.95 | 255 | 52.25 | |
Vaccine willingness history | |||||||
Never refused recommended vaccine | 210 | 76.64 | 200 | 93.46 | 410 | 84.02 | <0.001 *** |
Have refused recommended vaccine | 64 | 23.36 | 14 | 6.54 | 78 | 15.98 | |
Family member tested positive for COVID-19 | |||||||
No | 161 | 58.76 | 140 | 65.42 | 301 | 61.68 | 0.133 |
Yes | 113 | 41.24 | 74 | 34.58 | 187 | 38.32 | |
Friend tested positive for COVID-19 | |||||||
No | 24 | 8.76 | 22 | 10.28 | 46 | 9.43 | 0.568 |
Yes | 250 | 91.24 | 192 | 89.72 | 422 | 90.57 | |
Death of friend/family from COVID-19 | |||||||
No | 181 | 66.06 | 134 | 62.62 | 315 | 64.55 | 0.430 |
Yes | 93 | 33.94 | 80 | 37.38 | 173 | 35.45 | |
Perceived risk of becoming infected with COVID-19 | |||||||
Low or very low | 136 | 49.64 | 51 | 23.83 | 187 | 38.32 | <0.001 *** |
Fair | 79 | 28.83 | 90 | 42.06 | 169 | 34.63 | |
High or very high | 59 | 21.53 | 73 | 34.11 | 132 | 27.05 | |
Support mandatory COVID-19 vaccination in Saudi Arabia | |||||||
No | 268 | 97.81 | 78 | 36.45 | 346 | 70.90 | <0.001 *** |
Yes | 6 | 2.19 | 136 | 63.55 | 142 | 29.10 |
Variable | aOR | 95% CI | p-Value |
---|---|---|---|
Age (years) | |||
50 to 59 (ref) | |||
≥60 | 1.258 | 0.688–2.300 | 0.456 |
Gender | |||
Female (ref) | |||
Male | 2.277 | 1.092–4.745 | 0.028 ** |
Marital Status | |||
Unmarried (ref) | |||
Married | 0.632 | 0.260–1.535 | 0.311 |
Educational attainment | |||
High school or below (ref) | |||
University degree | 1.896 | 0.880–4.084 | 0.090 * |
Postgraduate degree | 3.040 | 1.270–7.277 | 0.013 ** |
Employment status | |||
Government employee (ref) | |||
Private sector employee | 0.449 | 0.165–1.226 | 0.118 |
Unemployed | 2.397 | 0.793–7.242 | 0.121 |
Retired | 0.957 | 0.457–2.004 | 0.908 |
Monthly Income (in SR) | |||
˂3000 | |||
3000–4999 | 2.728 | 0.395–18.856 | 0.309 |
5000–6999 | 1.963 | 0.307–12.565 | 0.477 |
7000–9999 | 3.169 | 0.604–16.619 | 0.172 |
10,000–14,999 | 1.736 | 0.350–8.623 | 0.500 |
15,000–19,999 | 1.582 | 0.316–7.914 | 0.577 |
20,000–29,999 | 1.285 | 0.248–6.668 | 0.765 |
≥30,000 | 2.560 | 0.502–13.052 | 0.258 |
Health status | |||
No chronic disease | |||
Chronic disease diagnosis | 1.169 | 0.668–2.044 | 0.585 |
Vaccination history | |||
Never received flu vaccine | |||
Have received flu vaccine | 1.661 | 0.959–2.878 | 0.070 * |
Vaccine willingness history | |||
Never refused recommended vaccine | |||
Have refused recommended vaccine | 0.358 | 0.154–0.830 | 0.017 ** |
Family member tested positive for COVID-19 | |||
No (ref) | |||
Yes | 1.098 | 0.612–1.969 | 0.755 |
Friend tested positive for COVID-19 | |||
No (ref) | |||
Yes | 1.132 | 0.406–3.158 | 0.812 |
Death of friend/family from COVID-19 | |||
No (ref) | |||
Yes | 1.035 | 0.589–1.818 | 0.905 |
Perceived risk of becoming infected with COVID-19 | |||
Low or very low (ref) | |||
Fair | 3.473 | 1.780–6.777 | <0.001 *** |
High or very high | 4.437 | 2.148–9.168 | <0.001 *** |
Support mandatory COVID-19 vaccination in Saudi Arabia | |||
No (ref) | |||
Yes | 101.761 | 39.173–264.348 | <0.001 *** |
Reason | n | % |
---|---|---|
Fear of adverse side effects | 74 | 27.01 |
Safety and efficacy concerns | 62 | 22.63 |
The speed of making the vaccine | 11 | 4.01 |
The short duration of clinical trials | 29 | 10.58 |
Personal desire not to be vaccinated | 20 | 7.30 |
I think the vaccine is a plot | 31 | 11.31 |
I do not believe in the existence of COVID-19 | 1 | 0.36 |
I feel that masks and sanitizers are sufficient for protection | 23 | 8.39 |
Other | 23 | 8.39 |
Total | 274 | 100 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Al-Hanawi, M.K.; Alshareef, N.; El-Sokkary, R.H. Willingness to Receive COVID-19 Vaccination among Older Adults in Saudi Arabia: A Community-Based Survey. Vaccines 2021, 9, 1257. https://doi.org/10.3390/vaccines9111257
Al-Hanawi MK, Alshareef N, El-Sokkary RH. Willingness to Receive COVID-19 Vaccination among Older Adults in Saudi Arabia: A Community-Based Survey. Vaccines. 2021; 9(11):1257. https://doi.org/10.3390/vaccines9111257
Chicago/Turabian StyleAl-Hanawi, Mohammed Khaled, Noor Alshareef, and Rehab H. El-Sokkary. 2021. "Willingness to Receive COVID-19 Vaccination among Older Adults in Saudi Arabia: A Community-Based Survey" Vaccines 9, no. 11: 1257. https://doi.org/10.3390/vaccines9111257
APA StyleAl-Hanawi, M. K., Alshareef, N., & El-Sokkary, R. H. (2021). Willingness to Receive COVID-19 Vaccination among Older Adults in Saudi Arabia: A Community-Based Survey. Vaccines, 9(11), 1257. https://doi.org/10.3390/vaccines9111257